Corindus Vascular Robotics

Corindus Vascular Robotics, Inc. engages in the provision of robotic-assisted vascular interventions. It provides CorPath platform for medical procedures. The company was founded by Tal Wenderow in 2002 and is headquartered in Waltham, MA.

Siemens Healthineers AG

NEWTON, Mass.--(BUSINESS WIRE)--Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today it presented the results of a first-of-its-kind study demonstrating the safety and effectiveness of robotic-assisted neurovascular aneurysm embolization using the CorPath GRX Neurovascular System. The data represents a milestone in the company's commitment to extending precision robotics into neurovascular treatment. The prospective, single-arm, intern

Corindus, A Siemens Healthineers Company, Announces Study Results Demonstrating Safety and Effectiveness of CorPath® GRX Neurovascular System

NEWTON, Mass.--(BUSINESS WIRE)--Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today the opening of its new headquarters at 275 Grove Street in Newton, Mass. Siemens Healthineers relocated the Corindus headquarters from its previous location in Waltham to accommodate company growth, doubling the size of the current location from 35,000 square feet to 77,000 square feet. The headquarters will serve as the global Center of Excellence for

Corindus Announces New Office Opening in Newton to Support Growth

Corindus Vascular (CVRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Corindus Vascular Robotics (CVRS) to Report a Decline in Earnings: What to Look Out for

Corindus Vascular Robotics' (CVRS) CEO Mark Toland on Q2 2019 Results - Earnings Call Transcript

Shares soar after the company announces that it has accepted a buyout offer.

Why Corindus Vascular Robotics Is Skyrocketing

Corindus Vascular Robotics (NYSE: CVRS) shares are trading higher after the company announced it will be acquired by Siemens Healthineers AG for $4.28 per share in cash representing an aggregate purchase price of $1.1 billion.

Corindus Vascular Robots To Be Acquired By Siemens Healthineers For $1.1B

Corindus Vascular (CVRS) delivered earnings and revenue surprises of -20.00% and 11.59%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Corindus Vascular Robotics (CVRS) Reports Q2 Loss, Tops Revenue Estimates

Siemens Healthineers AG said it will buy robotics firm Corindus for $1.1. billion to bolster its business of providing robotic assistance in operating rooms 
The post Healthineers To Buy Robotics Firm Corindus In $1.1 Billion Deal appeared first on Investor's Business Daily.

Healthineers To Buy Robotics Firm Corindus In $1.1 Billion Deal

Corindus Vascular Robotics (CVRS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Growth of its CorPath GRX robotics system is taking off as physician and patient acceptance is growing, with revenue doubling from a year ago from a small base.

Corindus Vascular Robotics Reached An Inflection Point

CVRS is well positioned to seize opportunities brought by the growing robotic surgery market.

Corindus Vascular Robotics: A Strong Buy In The Emerging Surgery Robotics Industry

Shares jump even though its first-quarter results fell short of Wall Street's estimates. What can explain the optimism?

Why Corindus Vascular Robotics Is Soaring Today

Corindus Vascular Robotics, Inc. (CVRS) CEO Mark Toland on Q1 2019 Results - Earnings Call Transcript

Corindus Vascular (CVRS) delivered earnings and revenue surprises of 0.00% and 4.69%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Corindus Vascular Robotics (CVRS) Reports Q1 Loss, Tops Revenue Estimates

Will Corindus Vascular Robotics (CVRS) Report Negative Earnings Next Week? What You Should Know

News that an insider is rapidly adding to his position has the stock heading higher.

News for Corindus Vascular Robotics Stock (CVRS)